Immune system pathway identified to fight allergens, asthma

May 07, 2008

For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Targeting these elements could result in more effective drugs to treat allergic disorders and asthma, according to a study reported in the May edition of the journal Nature Medicine.

Dendritic cells are vital to immune response in that they recognize, capture and introduce threatening organisms to T lymphocytes other immune cells that secrete potent proteins called cytokines that surround and destroy the invaders. However, the Pittsburgh team’s study goes further to illuminate a pathway that allergens use to act directly on dendritic cells to propel differentiation into the T lymphocytes that fight back.

“We now have identified a molecule, c-Kit, that is central to the process of allergic response,” said Anuradha Ray, Ph.D., co-corresponding author and professor of medicine and immunology in the Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine. “We show that genes encoding for c-Kit and the cytokine interleukin 6 (IL-6) are significantly activated when allergens are present, but c-Kit is the very first molecule that gets triggered.”

Interactions between viruses and bacteria and molecular steps that initiate the immune defense have remained largely unknown. Using cells cultured from c-Kit mutant mice, Dr. Ray, her husband and co-corresponding author Prabir Ray, Ph.D., and their colleagues studied molecular reactions to assaults by cholera toxin and a standard allergen, house dust mites. In addition to c-Kit and IL-6, they found effects on stem cell factor and Jagged-2 immune system molecules that are parts of the activation process.

“We have known the T-cell side of the story for many years, and we know that dendritic cells are important, but what we did not know was how the dendritic cell does what it does,” said Dr. Prabir Ray. “Therapy directed against c-Kit specifically on dendritic cells using compounds coupled to c-Kit inhibitors such as Gleevec, a drug that is already FDA-approved and used in cancer treatment, may alleviate allergic diseases and, potentially, inflammatory bowel disease.”

The Pittsburgh team incubated dendritic cells with cholera toxin and house dust mite allergens, finding that both substances induced significant secretion of c-Kit and IL-6, initial steps in a cascade resulting in the activation of T helper cells.

“Dual upregulation of c-Kit and stem cell factor has been noted in some cancers, such as small cell lung cancer. IL-6 has been associated with cancers such as multiple myeloma,” said Dr. Anuradha Ray. “Collectively, similar approaches to inhibit c-Kit, in addition to Gleevec or other inhibiting compounds could alleviate multiple cancers.”

Source: University of Pittsburgh

Explore further: Australian treatment could save wounded soldiers

add to favorites email to friend print save as pdf

Related Stories

Form Devices team designs Point as a house sitter

13 hours ago

A Scandinavian team "with an international outlook" and good eye for electronics, software and design aims to reach success with what they characterize as "a softer take" on home security. Their device is ...

Man pleads guilty in New York cybercrime case

16 hours ago

A California man has pleaded guilty in New York City for his role marketing malware that federal authorities say infected more than a half-million computers worldwide.

Recommended for you

A hybrid vehicle that delivers DNA

23 hours ago

A new hybrid vehicle is under development. Its performance isn't measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

DeeSmith
not rated yet May 07, 2008
One word: betaine (trimethylglycine). Natural sources: beets, broccoli, spinach. Betaine, found in plant cell walls, is a cellular modulator of histamine action. Histamine acts on dendritic cells, polarizing them during maturation and this affects the type and amount of cytokines they produce. Couple freebie papers on the internet worth reading:

Histamine Polarizes Human Dendritic Cells into Th2 Cell-Promoting Effector Dendritic Cells.
http://www.jimmun...7/7/3682

Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization.
http://www.pubmed...d=209473

"Atopic diseases such as allergy and asthma are characterized by increases in Th2 cells and serum IgE antibodies. The binding of allergens to IgE on mast cells triggers the release of several mediators, of which histamine is the most prevalent." "Histamine..dramatically altered the repertoire of cytokines and chemokines secreted by mature DCs (dendritic cells). We propose that the Th2 cells favor IgE production, leading to increased histamine secretion by mast cells, thus creating a positive feedback loop that could contribute to the severity of atopic diseases."

Bingo. Diet that lacks betaine, an important methyl group donor in the transulfuration pathway, tends to contribute to chronic hypersensitivity to common allergens and plays a role in the development of immune cell dysregulation underlying asthmatic.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.